FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
 
Skip Navigation LinksHome / News / Read News

Print

AFC Gamma Provides Justice Cannabis $22MM Credit Facility to Fund New Jersey Expansion

May 07, 2021, 08:08 AM
Filed Under: Cannabis
Related: AFC Gamma, Cannabis

AFC Gamma provided a credit facility of $22 million to Justice Cannabis Co., a Chicago-based multi-state operator with licenses in eight states. The credit facility is designed to provide Justice Cannabis Co. with the capital necessary to purchase and complete the build out of its 72,000 square foot cultivation and processing facility, along with the buildout of a dispensary, both in Ewing, New Jersey.

“We are pleased to support Justice Cannabis Co. as it continues to expand its operations in New Jersey,” said Leonard M. Tannenbaum, AFC’s Chief Executive Officer. “With adult use marijuana recently legalized in the state, we believe New Jersey will have favorable supply and demand dynamics for years to come and we are excited to be working with Justice Cannabis Co. in order to fully capitalize on this growing market.”

Jon Loevy, Justice Cannabis Co.’s Founder, added, “As we continue building on our presence in this highly attractive cannabis market, we are very excited to have the support and partnership of AFC. AFC has proven investment expertise in the cannabis space and provided us with an institutionally minded financing solution that supports our specific needs. We look forward to continuing to work with AFC to achieve our objectives.”

AFC will hold the entire $22 million of the credit facility, which consists of a first-lien term loan. The loan is secured by first-lien mortgages on Justice Cannabis Co.’s wholly owned real estate properties in New Jersey and other commercial-security interests. AFC Management, LLC served as Lead Arranger and Administrative Agent for the transaction.

New Jersey legalized the use of medical marijuana in 2010, with sales launching in 2019. Adult use marijuana was legalized in 2021. By 2024, the state expects to achieve sales of between $850 million and $950 million, with significant opportunities to exceed this range, depending on licensing details which will be developed over time.








Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.